Stimulus‐Responsive Drug Delivery Nanoplatforms for Osteoarthritis Therapy

Abstract Osteoarthritis (OA) is one of the most prevalent age‐related degenerative diseases. With an increasingly aging global population, greater numbers of OA patients are providing clear economic and societal burdens. Surgical and pharmacological treatments are the most common and conventional therapeutic strategies for OA, but often fall considerably short of desired or optimal outcomes. With the development of stimulus‐responsive nanoplatforms has come the potential for improved therapeutic strategies for OA. Enhanced control, longer retention time, higher loading rates, and increased sensitivity are among the potential benefits. This review summarizes the advanced application of stimulus‐responsive drug delivery nanoplatforms for OA, categorized by either those that depend on endogenous stimulus (reactive oxygen species, pH, enzyme, and temperature), or those that depend on exogenous stimulus (near‐infrared ray, ultrasound, magnetic fields). The opportunities, restrictions, and limitations related to these various drug delivery systems, or their combinations, are discussed in areas such as multi‐functionality, image guidance, and multi‐stimulus response. The remaining constraints and potential solutions that are represented by the clinical application of stimulus‐responsive drug delivery nanoplatforms are finally summarized.